glp 1 agonists in development Another milestone the evolution of GLP-1-based diabetes therapies GLP-1 Receptor Agonists in Solid

How GLP-1 and GIP pathways work, why dual-action tirzepatide (Mounjaro) differs from GLP-1-only medicines, and what trial averages mean for UK patients.

GLP-1RAs reduce events linked to atherogenic cardiovascular disease (especially ischemic stroke) and also renal outcomes (FLOW trial with semaglutide), with a limited effect on heart failure

Those who took Ozempic or a similar drug had a 40% lower chance of overdosing on opioids and a 50% lower chance of getting drunk compared to those who didn't take the medication, the study found.

Once weekly subcutaneous injection, gradually titrated by your provider

What is Akkermansia muciniphila

The European Medicines Agency has issued a positive recommendation on the same indication